Cedar Brook Financial Partners’s West Pharmaceutical WST Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-766	Closed	-$303K	–	424
2024 Q1	$303K	Hold	766	–	–	0.06%	311
2023 Q4	$272K	Sell	766 -16	-2%	-$5.66K	0.06%	318
2023 Q3	$293K	Hold	782	–	–	0.08%	260
2023 Q2	$299K	Sell	782 -13	-2%	-$4.64K	0.07%	283
2023 Q1	$275K	Buy	+795	New	+$232K	0.07%	280
2022 Q3	–	Sell	-801	Closed	-$242K	–	370
2022 Q2	$242K	Sell	801 -13	-2%	-$4.23K	0.08%	288
2022 Q1	$334K	Buy	814 +9	+1%	+$3.52K	0.09%	252
2021 Q4	$378K	Sell	805 -46	-5%	-$19.8K	0.1%	226
2021 Q3	$361K	Sell	851 -23	-3%	-$9.7K	0.11%	216
2021 Q2	$314K	Hold	874	–	–	0.09%	258
2021 Q1	$246K	Buy	874 +12	+1%	+$3.43K	0.09%	271
2020 Q4	$244K	Sell	862 -30	-3%	-$8.42K	0.09%	264
2020 Q3	$245K	Sell	892 -24	-3%	-$6.35K	0.1%	237
2020 Q2	$208K	Buy	+916	New	+$180K	0.09%	253
2020 Q1	–	Sell	-2,058	Closed	-$309K	–	307
2019 Q4	$309K	Buy	2,058 +18	+0.9%	+$2.62K	0.13%	198
2019 Q3	$289K	Buy	2,040 +8	+0.4%	+$1.1K	0.13%	211
2019 Q2	$254K	Hold	2,032	–	–	0.12%	238
2019 Q1	$224K	Buy	+2,032	New	+$211K	0.11%	248